New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
17:42 EDTRHHBY, CPHDCepheid says Roche patent suit will not have material adverse impact on results
Cepheid (CPHD) management stated that they have not had the opportunity to review the claim made by Roche (RHHBY) regarding a patent suit filed earlier; however management stated that it is their understanding that the patent has expired. Either way, the lawsuit will not have a material adverse impact on the company's results.
News For CPHD;RHHBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2015
05:28 EDTCPHDCepheid initiated with an Equal Weight at Barclays
Subscribe for More Information
August 27, 2015
07:51 EDTRHHBYRoche catching up fast to Bristol-Myers in immuno-oncology, says Jefferies
Subscribe for More Information
August 25, 2015
09:43 EDTCPHDCepheid issued warning letter from FDA following site inspection
Subscribe for More Information
August 24, 2015
12:01 EDTRHHBYRoche buys nucleic acid purification technology from Lumora
Roche has signed a definitive asset purchase agreement with Lumora for products associated with the patent-protected Heat Elution technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.
08:29 EDTCPHDWilliam Blair to hold a field trip
Subscribe for More Information
August 23, 2015
12:35 EDTRHHBYBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 21, 2015
09:38 EDTRHHBYUBS global healthcare analysts hold an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use